Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Nitin K. Hingankar"'
Autor:
Renu Garg, Padmini Srikantiah, Smita R. Thorat, Sandhya Kabra, D. C. S. Reddy, S. Rajasekaran, S Kumar, Srikanth Tripathy, Alaka Deshpande, Nitin K. Hingankar, Sharda R. Datkar, P. S. Deshmukh, Smita Kulkarni, Suvarna Sane, Michael R. Jordan, Devidas N. Chaturbhuj, Ramesh S. Paranjape, C. Chandrasekar
Publikováno v:
Clinical Infectious Diseases. 54:S348-S354
Human immunodeficiency virus drug resistance (HIVDR) in cohorts of patients initiating antiretroviral therapy (ART) at clinics in Chennai and Mumbai, India, was assessed following World Health Organization (WHO) guidelines. Twelve months after ART in
Autor:
Devidas N. Chaturbhuj, Smita R. Thorat, Velura Chandrasekhar, Sharda R. Datkar, Dandu C.S. Reddy, Padmini Srikantiah, Renu Garg, Nitin K. Hingankar, Sandhya Kabra, Srikanth Tripathy, Partha Haldar, Ramesh S. Paranjape, Damodar Bachani, Rajasekhar Koppada
Publikováno v:
AIDS Research and Human Retroviruses. 27:1291-1297
The World Health Organizations HIV Drug Resistance (WHO HIVDR) Threshold survey method was used to assess transmitted HIVDR in newly diagnosed HIV-1-infected primigravida women attending the Prevention of Parent to Child Transmission (PPTCT) centers
Autor:
Srikanth Tripathy, Praveen Deshmukh, Amita Gupta, Girish N. Nadkarni, Sarah E. Hudelson, Nitin K. Hingankar, Maria M. James, Susan H. Eshleman, Ramesh S. Paranjape, Dattaray G. Saple, Devidas N. Chaturbhuj, Bijal Shah, Louise Walshe, Satish B. Vaidya
Publikováno v:
AIDS Research and Human Retroviruses. 26:25-31
HIV-infected patients receiving antiretroviral (ARV) therapy (ART) in India are not all adequately virally suppressed. We analyzed ARV drug resistance in adults receiving ART in three private clinics in Mumbai, India. HIV viral load was measured in 2
Autor:
Devidas N. Chaturbhuj, Srikanth Tripathy, Sourav Sen, Rajiv Mohan Gupta, Nitin K. Hingankar, Rajesh T. Patil, Ramesh S. Paranjape
Publikováno v:
ISRN AIDS
Introduction. In India, 4,86,173 HIV infected patients are on first line antiretroviral therapy (ART) as of January 2012. HIV drug resistance (HIVDR) is drug and regimen-specific and should be balanced against the benefits of providing a given ART re
Autor:
Nitin K. Hingankar, K. Siddhaarth, P. S. Deshmukh, Devidas N. Chaturbhuj, Sandhya Kabra, Ramesh S. Paranjape, Srikanth Tripathy, Sourav Sen, Sohan N. Deshpande
Publikováno v:
Journal of virological methods. 189(1)
An in-house method was evaluated for its efficiency to detect the HIV-1 drug resistance mutations. This method was compared with the ViroSeq™ Genotyping System 2.0 (Celera Diagnostics, US) a gold standard. Sixty-five stored plasma samples, previous
Autor:
Sharda R. Datkar, Padmini Srikantiah, Anita Ramachandran, Devidas N. Chaturbhuj, Sujatha Rao, Srikanth Tripathy, Nitin K. Hingankar, P. S. Deshmukh, Nayana Ingole, Sandhya Kabra, Meenakshi Mathur, Damodar Bachani, Partha Haldar, D C S Reddy, Renu Garg, Ramesh S. Paranjape, Sushma Jadhav, Preeti Mehta, Smita R. Thorat
Publikováno v:
AIDS research and human retroviruses. 26(8)
A survey for transmitted HIV drug resistance (HIVDR) was conducted according to WHO guidelines among clients newly diagnosed with HIV-1 infection at two voluntary counseling and testing centers (VCTC) in Mumbai. HIVDR testing was performed using the
Autor:
Smita R. Thorat, Devidas N. Chaturbhuj, Nitin K. Hingankar, Velura Chandrasekhar, Rajasekhar Koppada, Sharda R. Datkar, Padmini Srikantiah, Renu Garg, Sandhya Kabra, Partha Haldar, Dandu C.S. Reddy, Damodar Bachani, Srikanth P. Tripathy, Ramesh S. Paranjape
Publikováno v:
AIDS Research & Human Retroviruses; Dec2011, Vol. 27 Issue 12, p1291-1297, 7p
Autor:
Devidas N. Chaturbhuj, Nitin K. Hingankar, Padmini Srikantiah, Renu Garg, Sandhya Kabra, Pravin S. Deshmukh, Sushma D. Jadhav, Smita R. Thorat, Sharda R. Datkar, Preeti Mehta, Nayana Ingole, Meenakshi Mathur, Anita Ramachandran, Partha Haldar, D.C.S. Reddy, Damodar Bachani, Sujatha Rao, Srikanth P. Tripathy, Ramesh S. Paranjape
Publikováno v:
AIDS Research & Human Retroviruses; Aug2010, Vol. 26 Issue 8, p927-932, 6p
Publikováno v:
BMC Infectious Diseases
Methods HIV-1 Subtype C molecular infectious clone pIndieC (Genebank AB023804) was used to construct two experimental vectors, pIndieC consInC RTWILD and pIndieC consInC RTSYNM, which are identical except for the presence of four synonymous nucleotid